Alexander Titus, Assistant Director for Biotechnology in the Office of the Under Secretary of Defense for Research & Engineering (OUSD(R&E)), U.S. Department of Defense Dr. Alexander Titus is currently the Assistant Director (AD) for Biotechnology within the Office of the Under Secretary of Defense for Research & Engineering (OUSD(R&E)). As the [...]
Dipnath Baidyaroy, Senior Director at Codexis Dipnath is mostly interested in creating new businesses, products, and alliances in non-pharmaceutical applications. Use of Codexis enzyme engineering technology to enable new products and/or improve current products as a principal value-add is central to this strategy. Dipnath also governs strategic alliances at Codexis including [...]
Dan Wattendorf, director of Innovative Technology Solutions, Bill & Melinda Gates Foundation Dan Wattendorf, director of Innovative Technology Solutions at the Bill & Melinda Gates Foundation, leads efforts to identify and create biotechnology platforms that result in new options for global health and oversees the foundation’s strategy to develop and implement [...]
Felix Moser, Chief Scientific Officer of Synlife Felix Moser is the Chief Scientific Officer of Synlife, an early-stage startup based in Cambridge, MA developing novel healthcare solutions based on Synthetic Minimal Cell (SynellTM) technologies. Synthetic minimal cells, unlike extant organisms, offer the advantages of being wholly defined in their chemical makeup while [...]
Director, Synthetic Biology Research at Twist Bioscience Dr. Rebecca Nugent joined Twist Bioscience after spending many years in the biofuels and green chemicals industry. Dr. Nugent leads R&D teams at Twist Bioscience focused on the development of Synthetic Biology and Next-Generation Sequencing Target Enrichment (NGS TE) products. Dr. Rebecca Nugent received [...]
Rob McBride, Co-founder of Felix Biotechnology. Rob spent the last 10 years in the biotechnology industry leveraging microbes to tackle meaningful challenges. He cofounded Felix with colleagues from Yale and Berkeley to leverage a powerful new phage approach for managing bacterial infections.
Justin Jarrell, Lead scientist at Indee Labs. Justin Jarrell, PhD, is lead scientist at Indee Labs. He is guiding development of gentle and scaleable hardware using microfluidic vortex shedding (µVS) to manufacture engineered cellular therapies including chimeric antigen receptor T cells. Justin received his PhD in Immunology at Stanford University where [...]
Molly Morse, CEO and co-founder of Mango Materials Dr. Molly Morse is the CEO and co-founder of Mango Materials, a San Francisco Bay Area-based, next generation, biomanufacturing, start-up company. Mango Materials converts abundant methane gas into low-cost, high-value, biodegradable materials. We believe waste facilities are the goldmines of the future and [...]
Jun Axup, Scientific Director and Partner of IndieBio Dr. Jun Axup, PhD, is Scientific Director and Partner of IndieBio, the world’s leading biotech accelerator. She holds a PhD in chemical biology from The Scripps Research Institute and has worked at several startups in the fields of immuno-oncology, protein engineering, lab automation [...]
Jason Poulos, CEO of Librede Dr. Jason Poulos is CEO of Librede Inc., a Carlsbad based biotechnology company. His background has focused on bioengineering and the commercialization of innovative synthetic biology-based technologies. At Librede, Dr. Poulos oversees the development of microorganism-based platforms to produce natural products found in plants. Dr. Poulos [...]
